Treatment Study for Active Ulcerative Colitis
An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Subjects with Moderately to Severely Active Ulcerative Colitis
- Sex: Any
- Age: Child (Birth - 17)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase II
- Conditions Being Studied: Ulcerative Colitis
Study Purpose
The purpose of this study is to assess an investigational drug called etrasimod (also referred to as the “study drug”) in the treatment of moderately to severely active ulcerative colitis.
Who Can Participate
Age: 12-18
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
UH Rainbow Babies & Children’s Ahuja Center for Women & Children
5805 Euclid Ave
Cleveland OH, 44103
UH Westlake Health Center
960 Clague Rd
Westlake OH, 44145
- UH IRB: STUDY20220204
- StudyID: 2022-0884
- ClinicalTrials.gov: NCT05287126
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422